The hyper-inflammatory phase, which is initiated by tumor necrosis factor-α (TNFα) and subsequently amplified by interleukin-1 (IL-1) and IL-64, 10, may, together with downstream mediators, lead to endothelial dysfunction, characterized by vasodilation and increased permeability. The gene discussed is TNF; the disease is endothelial dysfunction.